List of Excipients in API neomycin sulfate, polymyxin b sulfate, and dexamethasone
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing neomycin sulfate, polymyxin b sulfate, and dexamethasone
Detailed excipient profiles for neomycin sulfate, polymyxin b sulfate, and dexamethasone
Excipient focus: LANOLIN
neomycin sulfate, polymyxin b sulfate, and dexamethasone drug variants containing LANOLIN
neomycin sulfate, polymyxin b sulfate, and dexamethasone drug variants not containing LANOLIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
neomycin sulfate, polymyxin b sulfate, and dexamethasone drug variants containing METHYLPARABEN
neomycin sulfate, polymyxin b sulfate, and dexamethasone drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MINERAL OIL
neomycin sulfate, polymyxin b sulfate, and dexamethasone drug variants containing MINERAL OIL
neomycin sulfate, polymyxin b sulfate, and dexamethasone drug variants not containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PETROLATUM
neomycin sulfate, polymyxin b sulfate, and dexamethasone drug variants containing PETROLATUM
neomycin sulfate, polymyxin b sulfate, and dexamethasone drug variants not containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
neomycin sulfate, polymyxin b sulfate, and dexamethasone drug variants containing PROPYLPARABEN
neomycin sulfate, polymyxin b sulfate, and dexamethasone drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
